Capricor Therapeutics (CAPR) Goodwill & Intangibles (2012 - 2021)
Capricor Therapeutics (CAPR) posted quarterly Goodwill & Intangibles of $1083.0 for Q1 2021, down 79.99% year-over-year from $5413.0 in Q1 2020, and down 49.98% quarter-over-quarter from $2165.0 in Q4 2020.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Goodwill & Intangibles (2012 - 2021) Analysis & Trends
Capricor Therapeutics' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $1083.0 for Q1 2021.
- In Q1 2021, Goodwill & Intangibles fell 79.99% year-over-year to $1083.0; the TTM figure through Mar 2021 stood at $1083.0 (down 79.99% YoY), while the FY2020 annual figure was $2165.0, down 66.67% from the prior year.
- Goodwill & Intangibles for Q1 2021 stood at $1083.0, down from $2165.0 in the prior quarter.
- The five-year high for Goodwill & Intangibles was $130066.0 in Q1 2017, with the low at $1083.0 in Q1 2021.
- The 5-year median for Goodwill & Intangibles is $38952.0 (2019), against an average of $48107.1.
- Peak annual rise in Goodwill & Intangibles reached 31.56% in 2017, while the deepest fall reached 92.14% in 2017.
- Capricor Therapeutics' Goodwill & Intangibles stood at $93048.0 in 2017, then slumped by 46.51% to $49772.0 in 2018, then plunged by 86.95% to $6495.0 in 2019, then slumped by 66.67% to $2165.0 in 2020, then sank by 49.98% to $1083.0 in 2021.
- Business Quant data shows CAPR's Goodwill & Intangibles at $1083.0 in Q1 2021, $2165.0 in Q4 2020, and $3248.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 543.30 Mn | 543.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 1,083.00 |
| Dec 31, 2020 | 2,165.00 |
| Sep 30, 2020 | 3,248.00 |
| Jun 30, 2020 | 4,330.00 |
| Mar 31, 2020 | 5,413.00 |
| Dec 31, 2019 | 6,495.00 |
| Sep 30, 2019 | 17,314.00 |
| Jun 30, 2019 | 28,133.00 |
| Mar 31, 2019 | 38,952.00 |
| Dec 31, 2018 | 49,772.00 |
| Sep 30, 2018 | 60,591.00 |
| Jun 30, 2018 | 71,410.00 |
| Mar 31, 2018 | 82,229.00 |
| Dec 31, 2017 | 93,048.00 |
| Sep 30, 2017 | 105,692.00 |
| Jun 30, 2017 | 117,879.00 |
| Mar 31, 2017 | 130,066.00 |
| Dec 31, 2016 | 142,253.00 |
| Sep 30, 2016 | 1.50 Mn |
| Jun 30, 2016 | 1.50 Mn |